Sana Biotechnology Inc Strategic Asset Allocation Index
Sana Biotechnology Inc strategic asset allocation index. Sana Biotechnology Inc (SANA) has a Strategic Asset Allocation Index of 0.0% as of December 2023. Strategic assets (PP&E of $- plus long-term investments of $0.00) total $0.00, measured against net assets of $287.51 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check how tangible is Sana Biotechnology Inc's equity to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Sana Biotechnology Inc (2021–2023)
Strategic asset allocation index of Sana Biotechnology Inc from 2021 to 2023. This chart shows how Sana Biotechnology Inc's Strategic Asset Allocation Index has evolved across 3 annual periods from 2021 to 2023. As of December 2023, the index stands at 0.0%, representing strategic assets of $0.00 against net assets of $287.51 Million USD.
Sana Biotechnology Inc Strategic Asset Allocation Index by Year (2021–2023)
Sana Biotechnology Inc strategic asset allocation index by year from 2021 to 2023. The table below presents the year-by-year Strategic Asset Allocation Index for Sana Biotechnology Inc from 2021 to 2023, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Sana Biotechnology Inc (SANA) market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 0.0% | $0.00 | $- | $0.00 | $287.51 Million | ▼ -15.4 pp |
| 2022 | 15.4% | $76.97 Million | $66.92 Million | $10.05 Million | $499.31 Million | ▼ -20.5 pp |
| 2021 | 35.9% | $261.35 Million | $65.46 Million | $195.88 Million | $728.50 Million | — |